The activin-follistatin system in the neonatal ovine uterus

Biology of Reproduction

Volumn 69, Issue 3, 2003, Pages 843-850

  Hayashi, Kanako ^a   Carpenter, Karen D ^a   Gray, C Allison ^a   Spencer, Thomas E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Activin; Developmental biology; Follistatin; Inhibin; Uterus

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 1; FOLLISTATIN; INHIBIN A; INHIBIN B; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYOMETRIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; UTERUS GROWTH;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL DIVISION; ENDOMETRIUM; EPITHELIUM; FEMALE; FOLLISTATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INHIBIN-BETA SUBUNITS; INHIBINS; MORPHOGENESIS; MYOMETRIUM; RNA, MESSENGER; SHEEP;

ANIMALIA; OVIS; OVIS ARIES;

EID: 0043009726     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.016287     Document Type: Article

References (46)

1. Wiley AA, Bartol FF, Barron DH. Histogenesis of the ovine uterus. J Anim Sci 1987; 64:1262-1269.
2. Taylor KM, Gray CA, Joyce MM, Stewart MD, Bazer FW, Spencer TE. Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biol Reprod 2000; 63:1192-1204.
3. Taylor KM, Chen C, Gray CA, Bazer FW, Spencer TE. Expression of messenger ribonucleic acids for fibroblast growth factors 7 and 10, hepatocyte growth factor, and insulin-like growth factors and their receptors in the neonatal ovine uterus. Biol Reprod 2001; 64:1236-1246.
4. Gray CA, Taylor KM, Bazer FW, Spencer TE. Mechanisms regulating norgestomet inhibition of endometrial gland morphogenesis in the neonatal ovine uterus. Mol Reprod 2000; 57:67-78.
5. Carpenter KD, Gray CA, Noel SD, Gertler A, Bazer FW, Spencer TE. Prolactin regulation of neonatal ovine uterine gland morphogenesis. Endocrinology 2003; 144:110-120.
6. Kennedy JP, Worthington CA, Cole ER. The post-natal development of the ovary and uterus of the Merino lamb. J Reprod Fertil 1974; 36:275-282.
7. Wimsatt WA. New histological observations on the placenta of the sheep. Am J Anat 1950; 87:391-436.
8. Stewart MD, Johnson GA, Gray CA, Burghardt RC, Schuler LA, Joyce MM, Bazer FW, Spencer TE. Prolactin receptor and uterine milk protein expression in the ovine endometrium during the estrous cycle and pregnancy. Biol Reprod 2000; 62:1779-1789.
9. Bartol FF, Wiley AA, Floyd JG, Ott TL, Bazer FW, Gray CA, Spencer TE. Uterine differentiation as a foundation for subsequent fertility. J Reprod Fertil Suppl 1999; 53:284-300.
10. Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE. Developmental biology of uterine glands. Biol Reprod 2001; 65:1311-1323.
11. Ritvos O, Tuuri T, Eramaa M, Sainio K, Hilden K, Saxen L, Gilbert SF. Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech Dev 1995; 50:229-245.
12. Hilden K, Tuuri T, Eramaa M, Ritvos O. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 1994; 83:2163-2170.
13. Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994; 134:914-923.
14. Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin βA- and βB-subunits and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994; 78:1521-1524.
15. Cancilla B, Jarred RA, Wang H, Mellor SL, Cunha GR, Risbridger GP. Regulation of prostate branching morphogenesis by activin A and follistatin. Dev Biol 2001; 237:145-158.
16. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L. Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 1996; 56:1155-1163.
17. Zhao Y, Silbajoris R, Young SL. Identification and developmental expression of two activin receptors in baboon lung. Biochem Biophys Res Commun 1996; 229:50-57.
18. Miralles F, Czernichow P, Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998; 125:1017-1024.
19. Furukawa M, Eto Y, Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocr J 1995; 42:63-68.
20. Yamaoka T, Idehara C, Yano M, Matsushita T, Yamada T, Ii S, Moritani M, Hata J, Sugino H, Noji S, Itakura M. Hypoplasia of pancreatic islets in transgenic mice expressing activin oceptor mutants. J Clin Invest 1998; 102:294-301.
21. Maldonado TS, Kadison AS, Crisera CA, Grau JB, Alkasab SL, Longaker MT, Gittes GK. Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J Gastrointest Surg 2000; 4:269-275.
22. Blauer M, Wichmann L, Punnonen R, Tuohimaa P. Measurement of activin B in human salivary and localization of activin subunits in ratsalivary glands. Biochem Biophys Res Commun 1996; 222:230-235.
23. Ethier JF, Findlay JK. Roles of activin and its signal transduction mechanisms in reproductive tissues. Reproduction 2001; 121:667-675.
24. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med 2002; 227:724-752.
25. Wrana JL, Attisano L. The Smad pathway. Cytokine Growth Factor Rev 2000; 11:5-13.
26. Xu J, McKeehan K, Matsuzaki K, Mckeehan WL. Inhibin antagonizesinhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 1995; 270:6308-6313.
27. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad SciU S A 1998; 95:9337-9342.
28. Ball EM, Risbridger GP. Activins as regulators of branching morphogenesis. Dev Biol 2001; 238:1-12.
29. Nakamum T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 1990; 247:835-838.
30. De Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijden-vanRaaij AJ. Follistatin neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996; 116:105-114.
31. Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 1998; 19:287-322.
32. Carpenter KD, Hayashi K, Spencer TE. Ovarian regulation of endometrial gland morphogenesis and the activin-follistatin system in the neonatal ovine uterus. Biol Reprod 2003; 69:851-860.
33. Spencer TE, Gray CA, Joyce MM, Jenster G, Wood CG, Bazer FW, Wiley AA, Bartol FF. Discovery and characterization of endometrial epithelial messenger ribonucleic acids using the ovine uterine gland knockout model. Endocrinology 1999; 140:4070-4080.
34. Spencer TE, Ing NH, Ott TL, Mayes JS, Becker WC, Watson GH, Mirando MA, Bazer FW. Intrauterine injection of ovine interferon-τ alters oestrogen receptor and oxytocin receptor expression in the endometrium of cyclic ewes. J Mol Endocrinol 1995; 15:203-220.
35. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley A. Functional analysis of activins during mammalian development. Nature 1995; 374:354-356.
36. Robinson GW, Hennighausen L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 1997; 124:2701-2708.
37. Mather JP, Moore A, Li RH. Activins, inhibins and follistatin: further thoughts on a growing family of regulators. Proc Exp Biol Med 1997; 215:209-222.
38. Maeshima A, Nojima Y, Kojima I. The role of the activin-follistatin system in the developmental and regeneration processes of the kidney. Cytokine Growth Factor Rev 2001; 12:289-298.
39. Mathews LS. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 1994; 15:310-325.
40. Massague J, Chen YG. Controlling TGF-β signaling. Genes Dev 2000; 14:627-644.
41. Chen W, Woodruff TK, Mayo KE. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and Smad proteins. Endocrinology 2000; 141:1263-1272.
42. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M, Nakano R. Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 1998; 91:685-692.
43. Ying SY, Zhang Z, Furst B, Batres Y, Huang G, Li G. Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 1997; 214:114-122.
44. Maeshima A, Zhang YQ, Furukawa M, Naruse T, Kojima I. Hepatocyte growth factor induces branching tubulogenesis in MDCK cells by modulating the activin-follistatin system. Kidney Int 2000; 58:1511-1522.
45. Braw-Tal R. Expression of mRNA for follistatin and inhibin/activin subunits during follicular growth and atresia. J Mol Endocrinol 1994; 13:253-264.
46. Braw-Tal R, Yossefi S, Zenou A, Bor A. Differential expression pattern of inhibin α and βA subunits in the ovaries of postnatal and prepubertal lambs. Reprod Fertil Dev 1997; 9:825-832.